US RNAi Therapeutics Market Trends 2031: Progress in Targeted Therapeutic Development
RNAi Therapeutics Market growth in the US is supported by pharmaceutical innovation, biotechnology investment, and research into targeted gene-silencing medicines. The RNAi Therapeutics Market was valued at US$ 1.5 billion in 2021 and is projected to reach US$ 3.2 billion by 2031, registering a CAGR of 16.5% during the forecast period from 2023 to 2031. Market growth is supported by advances in...
0 التعليقات 0 المشاركات 135 مشاهدة 0 معاينة